Concepedia

Guangjiang Jiang

GJ

6

Publications

355

Citations

6

H-Index

2019

Active since

Affiliations

Zhejiang University(Current)

First Affiliated Hospital Zhejiang University

Hangzhou First People's Hospital

McMaster University

Zhejiang Cancer Hospital

Guangjiang Jiang is an author at Zhejiang University specializing in hepatocellular carcinoma, medicine, and cancer research.

Top concepts

MedicineHepatocellular CarcinomaCancer ResearchRadiation OncologyOncologyHepatologyCell BiologyCancer BiologyLiver TransplantationPathology

Publications per year

2019–2022

6

Publications

6

USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1α/USP22 positive feedback loop upon TP53 inactivation

Sunbin Ling, Qiaonan Shan, Qifan Zhan et al. · Gut · 2019 · 216 citations

Mice Bearing Hcc, Cancer Biology, Redox Biology +24

Self‐Activated Cascade‐Responsive Sorafenib and USP22 shRNA Co‐Delivery System for Synergetic Hepatocellular Carcinoma Therapy

Shengjun Xu, Sunbin Ling, Qiaonan Shan et al. · Advanced Science · 2021 · 62 citations · Full text

Drug Targeting, Cancer Stemness, Novel Therapy +14

Hangzhou criteria as downstaging criteria in hepatocellular carcinoma before liver transplantation: A multicenter study from China

Qifan Zhan, Sunbin Ling, Yinan Deng et al. · Hepatobiliary & pancreatic diseases international · 2020 · 23 citations

Hepatology, Medicine, Histopathology +8

E2F7 promotes mammalian target of rapamycin inhibitor resistance in hepatocellular carcinoma after liver transplantation

Sunbin Ling, Qifan Zhan, Guangjiang Jiang et al. · American Journal of Transplantation · 2022 · 21 citations

Hepatology, Rapamycin Inhibitor Resistance, Medicine +7

Sirolimus-based immunosuppression improves outcomes in liver transplantation recipients with hepatocellular carcinoma beyond the Hangzhou criteria

Sunbin Ling, Tingting Feng, Qifan Zhan et al. · Annals of Translational Medicine · 2020 · 17 citations · Full text

Rows per page

1–5 of 6